We are live on ! Find out more
NDSI

Newman Dignan & Sheerar Inc Portfolio holdings

AUM $523M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
+3.17%
1 Year Est. Return
+26.16%
3 Year Est. Return
+73.46%
5 Year Est. Return
+76.54%
10 Year Est. Return
+279.61%
AUM
$388M
AUM Growth
+$13.7M
Cap. Flow
+$5.12M
Cap. Flow %
1.32%
Top 10 Hldgs %
38.96%
Holding
175
New
4
Increased
65
Reduced
80
Closed
6
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
126
Novartis
NVS
$297B
$394K 0.1%
3,699
TSN icon
127
Tyson Foods
TSN
$20.4B
$391K 0.1%
6,839
+61
+0.9% +$3.57K
FNDX icon
128
Schwab Fundamental US Large Company Index ETF
FNDX
$27.3B
$389K 0.1%
17,430
-900
-5% -$19.8K
TFC icon
129
Truist Financial
TFC
$64B
$387K 0.1%
9,969
+65
+0.7% +$2.46K
NKE icon
130
Nike
NKE
$61.9B
$383K 0.1%
5,081
-649
-11% -$60.3K
HACK icon
131
Amplify Cybersecurity ETF
HACK
$2.9B
$367K 0.09%
5,668
+252
+5% +$15.7K
VRTX icon
132
Vertex Pharmaceuticals
VRTX
$126B
$358K 0.09%
764
-33
-4% -$14.3K
MPLX icon
133
MPLX
MPLX
$59.7B
$353K 0.09%
8,300
WFC.PRL icon
134
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$337K 0.09%
283
+2
+0.7% +$2.35K
XLE icon
135
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$331K 0.09%
7,260
+150
+2% +$6.99K
TGT icon
136
Target
TGT
$68B
$329K 0.08%
2,224
+101
+5% +$15.9K
AON icon
137
Aon
AON
$76B
$329K 0.08%
1,120
-149
-12% -$44.1K
REGN icon
138
Regeneron Pharmaceuticals
REGN
$80.8B
$327K 0.08%
311
-167
-35% -$162K
VXUS icon
139
Vanguard Total International Stock ETF
VXUS
$160B
$309K 0.08%
5,118
+166
+3% +$10K
IBDV icon
140
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.28B
$299K 0.08%
14,062
+759
+6% +$16K
IBDS icon
141
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.85B
$298K 0.08%
12,550
+403
+3% +$9.53K
VOE icon
142
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$297K 0.08%
1,976
-616
-24% -$93.5K
VEA icon
143
Vanguard FTSE Developed Markets ETF
VEA
$236B
$296K 0.08%
5,997
+122
+2% +$6.07K
CARR icon
144
Carrier Global
CARR
$52.8B
$295K 0.08%
4,680
-14
-0.3% -$860
GPN icon
145
Global Payments
GPN
$22.8B
$295K 0.08%
3,046
-1,223
-29% -$135K
DD icon
146
DuPont de Nemours
DD
$19.2B
$293K 0.08%
2,905
MTUM icon
147
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
$292K 0.08%
1,497
+8
+0.5% +$1.49K
PYPL icon
148
PayPal
PYPL
$50.5B
$283K 0.07%
4,880
-46
-0.9% -$2.93K
CI icon
149
Cigna
CI
$74.6B
$283K 0.07%
856
AVUV icon
150
Avantis US Small Cap Value ETF
AVUV
$30.9B
$283K 0.07%
3,150

Similar funds

Newman Dignan & Sheerar Inc's Q2 2024 Portfolio in Review

As of Q2 2024, Newman Dignan & Sheerar Inc held 175 positions worth $388M, up 3.7% from $374M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Newman Dignan & Sheerar Inc's Q2 2024 filing shows 4 new, 65 increased, 80 reduced and 6 closed positions. Its largest new stake was iShares iBonds Dec 2029 Term Corporate ETF: 138,274 shares worth $3.13M. The largest sale was First Trust Smith Opportunistic Fixed Income ETF, an estimated $6.53M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.

  • Newman Dignan & Sheerar Inc's largest Q2 2024 buy was iShares iBonds Dec 2029 Term Corporate ETF: 138,274 shares worth $3.13M.
  • Newman Dignan & Sheerar Inc added most to Victory Portfolios II VictoryShares Core Intermediate Bond ETF in Q2 2024, an estimated $8.27M increase.
  • Newman Dignan & Sheerar Inc's biggest Q2 2024 reduction was ProShares S&P 500 Dividend Aristocrats ETF, cutting an estimated $1.55M.
  • Newman Dignan & Sheerar Inc fully exited First Trust Smith Opportunistic Fixed Income ETF in Q2 2024, selling an estimated $6.53M.
  • Newman Dignan & Sheerar Inc's ten largest holdings make up 39% of its $388M portfolio in Q2 2024.
  • Newman Dignan & Sheerar Inc opened 4 new positions and closed 6 in Q2 2024.
  • Newman Dignan & Sheerar Inc's portfolio value rose 3.7% quarter-over-quarter to $388M.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2024, filed 15 Jul 2024.